Want to join the conversation?
$KSS 2Q15 Q&A: Charles Grom from Sterne Agee asked about tax rate, SG&A & buy back. Wesley said, this year we'll end up around $930MM & tax rate to be around 37.5%. We’re more aggressive on buyback. We tend to target $250MM this quarter & ended up doing more than that. I think we're pretty close to $550 for spring season &our target still is $1Bil.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.